|
SCIENTIFIC PROGRAM Oral presentations |
|||
|
MORNING SESSION 8:30-13:15 |
Wednesday, September 18th |
||
|
Opening Lecture |
|||
|
08:30-09:15 |
The Economic Costs of Non-Melanoma Skin Cancer in the US. Gabriel Picone. PhD. USA |
||
|
09:15-11:45 |
SESSION 1 |
Detection and diagnosis of non-melanoma skin cancer |
|
|
Chairperson: Rigoberto Garcia, MD, (Cuba), Sonia Collazo Caballero,MD, (Cuba) |
|||
|
09:15-09:45 |
Epidemiology of skin cancer in Cuba. Olaine Gray Lovio. MD, Cuba. |
||
|
09:45-10:05 |
Clinical diagnosis of non-melanoma skin cancer.Sonia Collazo Caballero. MD, Cuba. |
||
|
10:05-10:25 |
Histologic diagnosis of non-melanoma skin cancer.Ernesto Arteaga Hernández. MD, Cuba. |
||
|
10:25-10:45 |
Biological behavior of BCC. Leticia Boeta. MD, Mexico. |
||
|
10:45-11:00 |
Molecular pathology of BCC. Dania Vazquez Blomquist. PhD, Cuba. |
||
|
11:00-11:15 |
New innovative non-invasive methods for diagnosis of non-melanoma skin cancer of head and neck. Jilliana Monnier. MD, France. |
||
|
11:15-11:45 |
Coffee Break |
||
|
11:45-13:15 |
SESSION 1 |
Treatment of non-melanoma skin cancer |
|
|
Chairperson: Olaine Gray, MD, (Cuba), Domenico Musumeci, MD, (Italy) |
|||
|
11:45-12:15 |
Head and neck basal cell carcinoma treatment. Domenico Musumeci. MD, Italy. |
||
|
12:15-12:30 |
Surgical treatment of BCC. Leticia Boeta. MD, Mexico. |
||
|
12:30-12:45 |
Adjuvant treatment with HeberFERON to surface radiation therapy. Presentation of two cases. Ania Noda Rodríguez. MD, Cuba. |
||
|
12:45-13:00 |
HeberFERON in real word. The experience of province of Matanzas. Yisel Piña Rodriguez, MD. Cuba |
||
|
13:00-13:15 |
Cuban National Program for HeberFERON treatment. Yutdelis Roben Aguilar. MSc, Cuba. |
||
|
13:15-14:15 |
Lunch |
||
|
AFTERNOON SESSION 14:30-17:30 |
Wednesday, September 18th |
||
|
14:15-15:30 |
SESSION 2 |
HeberFERON in non-melanoma skin cancer Multiple BCC |
|
|
Chairperson: Iraldo Bello Rivero, PhD, (Cuba), Dania Vázquez Blomquist, PhD, (Cuba) |
|||
|
14:15-14:45 |
HeberFERON in the management of BCC. Iraldo Bello Rivero. PhD, Cuba |
||
|
14:45-15:00 |
Treatment of BCC with HeberFERON by perilesional or intramuscular routes. Yakelín León García. MD, Cuba. |
||
|
15:00-15:15 |
Gorlin-Goltz Syndrome treated with HeberFERON. Case presentation. Vladimir Sanchez Linares. MD, Cuba. |
||
|
15:15-15:30 |
BCC in a child with Xeroderma pigmentosum treated with HeberFERON. Case presentation. Pilar Acuña Aguilarte. MD, Cuba. |
||
|
15:30-16:30 |
Poster session/ Free communications |
Diagnosis and treatment of BCC Mutidisciplinarity |
|
|
16:30 -17:30 |
Courses |
Dermatological surgery -Manuel Salazar Sedano. MD, Cuba |
|
|
Special Conferences |
Personalized therapy. Alexander Ortega Carballosa. MD, Cuba Hermanos Ameijeiras Hospital. |
||
|
SCIENTIFIC PROGRAM Oral presentations |
|||
|
MORNING SESSION 08:30-13:30 |
Thursday, September 19th |
||
|
08:30-11:00 |
SESSION 3 |
Interdisciplinarity and multidisciplinarity in Dermato-Oncology |
|
|
Chairperson: Ernesto Arteaga, MD (Cuba) , Yordan Martin. MD, (Cuba) |
|||
|
08:30-09:00 |
Multidisciplinarity in the management of BCC. Dunia Sotolongo Díaz. MD, Cuba |
||
|
09:00-09:30 |
Advanced non-melanoma skin cancer. The role of multidisciplinary teamwork. Mildrey García Hernández. MD. Cuba. |
||
|
09:30-10:00 |
Surgical management of basal cell carcinoma. Omar Jaimes Ramirez. MD, Colombia. |
||
|
10:00-10:30 |
Communitarian approach for diagnosis and treatment of BCC. Katherine Batista Ochoa. MD, Cuba |
||
|
10:30-10:50 |
Clinical response to HeberFERON treatment in patients with high risk BCC. Yordan Martin. MD, Cuba. |
||
|
10:50-11:00 |
Five years follow-up of patients with non-melanoma skin cancer treated with HeberFERON. Yaquelin Duncan. MD, Cuba. |
||
|
11:00-11:30 |
Coffee Break |
||
|
11:30-13:30 |
SESSION 3 |
Reconstructive surgery for head and neck non-melanoma skin cancer |
|
|
Chairperson: Corrado Fichera, MD, (Italy), Odalys Francis Turner, MD, (Spain) |
|||
|
11:30-12:00 |
Nasal reconstructive surgery in skin cancer patients. Corrado Fichera, MD. Italy. |
||
|
12:00-12:20 |
Basal cell carcinoma, HeberFERON a therapeutic option. Presentation of cases. Aurora Velázquez Martinez. DDS, Cuba. |
||
|
12:20-12:40 |
Plastic and reconstructive surgery. José Alfredo Neira Garza. MD, Mexico. |
||
|
12:40-13:00 |
Surgery of complex BCC. Manuel Salazar Sedano. MD, Cuba. |
||
|
13:00-13:30 |
HeberFERON avoid complex surgery. Case presentation. Marlene Curbelo Alonso. MD, Cuba. |
||
|
13:30-14:30 |
Lunch |
||
|
AFTERNOON SESSION 14:30-17:30 |
Thursday, September 19th |
||
|
14:30-15:30 |
SESSION 4 |
Target therapy and immunotherapy for skin cancer Precision medicine in non-melanoma skin cancer |
|
|
Chairperson: Morganna Freeman, MD, (USA) Lorenzo Anasagasti, MD, (Cuba) |
|||
|
14:30-14:45 |
Cutaneous Squamous Cell Carcinoma: Managing Advanced Disease in the Era of Immunotherapy. Morganna Freeman. MD, USA. |
||
|
14:45-15:00 |
Interdisciplinary approach. The role of HeberFERON. Lorenzo Anasagasti Angulo. MD. Cuba |
||
|
15:00-15:15 |
Tumor‐Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons. Lorenzo Memeo. MD, Italy. |
||
|
15:15-15:30 |
Clinical Research in Non-melanoma Skin Cancer. Precision medicine in Merkel Cell Carcinoma. Todd Knepper. PharmD, USA. |
||
|
Chairperson:Yisel Piña, MD, and Yanelda Garcia, MSc, Cuba |
|||
|
15:30-16:30 |
Poster session/ Free communications |
HeberFERON National Program in Cuba |
|
|
16:30-17:30
|
Courses |
Reconstructive surgery, Aesthetic Medicine and Facial Corrado Fichera, MD, Italy Rejuvenation" Odalys Francis Turner. MD, Spain |
|
|
Special conferences |
Superficial radiotherapy DITECSA |
||
